臨床試驗

Aveir Leadless Pacemaker Japan PMS

NCT：NCT07106788 · RECRUITING

NCT IDNCT07106788

狀態RECRUITING

開始日期2025-05-26

SponsorAbbott Medical Devices (INDUSTRY)

First posted2025-08-06

Last updated2026-05-13

簡要摘要

The primary purpose of the PMS is to collect safety information on the Aveir DR leadless cardiac pacemaker (LP) system in a population indicated for de novo dual-chamber pacing. Additionally, the PMS will collect data on rollover patients from the Aveir DR i2i IDE, Aveir AR LP in patients indicated for single-chamber pacing in the right atrium, and upgradeability in patients implanted with single-chamber Aveir atrial or ventricular LP that require an upgrade to a dual-chamber Aveir LP.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。